CDY 1.43% 7.1¢ cellmid limited

fillerina, page-5

  1. 27 Posts.
    lightbulb Created with Sketch. 77
    An interesting paper below concerning trial of the Crescina hair product of Labo.

    Seems very complementary to CDY’s products rather than a competitor since it is directed towards treatment of male alopecia and does not try to do the same as CDY’s lotion, the latter being for more general use and, importantly, being also effective for female use.

    Seems that presentation of the two products in the market in association might have a synergistic effect. Lets hope we soon find both selling in each of the geographical areas mentioned in my previous post.

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680633/
 
watchlist Created with Sketch. Add CDY (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.